Substance use, Unlike Dolutegravir, is Associated with Mood Symptoms in People Living with HIV.


Journal

AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133

Informations de publication

Date de publication:
Dec 2021
Historique:
accepted: 16 04 2021
pubmed: 28 4 2021
medline: 23 11 2021
entrez: 27 4 2021
Statut: ppublish

Résumé

Contradictory data have been reported concerning neuropsychiatric side effects of the first-line antiretroviral drug dolutegravir, which may be partly due to lack of control groups or psychiatric assessment tools. Using validated self-report questionnaires, we compared mood and anxiety (DASS-42), impulsivity (BIS-11), and substance use (MATE-Q) between dolutegravir-treated and dolutegravir-naive people living with HIV (PLHIV). We analyzed 194, mostly male, PLHIV on long-term treatment of whom 82/194 (42.3%) used dolutegravir for a median (IQR) of 280 (258) days. Overall, 51/194 (26.3%) participants reported DASS-42 scores above the normal cut-off, 27/194 (13.5%) were classified as highly impulsive, and 58/194 (29.9%) regularly used recreational drugs. Regular substance use was positively associated with depression (p = 0.012) and stress scores (p = 0.045). We observed no differences between dolutegravir-treated and dolutegravir-naive PLHIV. Our data show that depressed and anxious moods and impulsivity are common in PLHIV and associate with substance use and not with dolutegravir use.

Identifiants

pubmed: 33903997
doi: 10.1007/s10461-021-03272-2
pii: 10.1007/s10461-021-03272-2
pmc: PMC8602138
doi:

Substances chimiques

Heterocyclic Compounds, 3-Ring 0
Oxazines 0
Piperazines 0
Pyridones 0
dolutegravir DKO1W9H7M1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4094-4101

Subventions

Organisme : Aidsfonds
ID : P-29001

Informations de copyright

© 2021. The Author(s).

Références

Lancet HIV. 2017 Dec;4(12):e536-e546
pubmed: 28729158
Psychosom Med. 2008 May;70(4):505-11
pubmed: 18378865
Open Forum Infect Dis. 2019 Jun 03;6(6):ofz174
pubmed: 31198814
Lancet Infect Dis. 2013 Nov;13(11):927-35
pubmed: 24074642
J Clin Psychol. 2007 Oct;63(10):979-99
pubmed: 17828761
AIDS. 2017 Jul 31;31(12):1775-1777
pubmed: 28700395
J Acquir Immune Defic Syndr. 2017 Apr 1;74(4):423-431
pubmed: 27984559
Brain Behav. 2016 Nov 23;7(1):e00605
pubmed: 28127523
PLoS One. 2019 Feb 15;14(2):e0207970
pubmed: 30768609
Int J Psychiatry Med. 2006;36(3):283-97
pubmed: 17236696
Antiviral Res. 2019 Sep;169:104552
pubmed: 31283942
J Antimicrob Chemother. 2017 Jun 1;72(6):1752-1759
pubmed: 28333231
AIDS. 2017 Sep 10;31(14):2023-2024
pubmed: 28857781
AIDS. 2018 Jul 31;32(12):1551-1561
pubmed: 29746295
CNS Neurol Disord Drug Targets. 2015;14(6):811-8
pubmed: 25808896
Acta Psychiatr Scand Suppl. 1987;334:1-100
pubmed: 2887090
J Antimicrob Chemother. 2019 Apr 1;74(4):1035-1043
pubmed: 30561642
Antivir Ther. 2017;22(4):353-356
pubmed: 28008867
Psychosom Med. 2008 Jun;70(5):531-8
pubmed: 18541904
Lancet. 2010 Jul 31;376(9738):367-87
pubmed: 20650518
Front Psychol. 2020 May 28;11:1005
pubmed: 32547451
AIDS. 2017 May 15;31(8):1201-1203
pubmed: 28441180
J Antimicrob Chemother. 2015 Oct;70(10):2693-708
pubmed: 26203180
HIV Med. 2018 May;19(5):e62-e63
pubmed: 28762661
J Neurovirol. 2019 Feb;25(1):85-90
pubmed: 30478800
AIDS. 2017 Jan 28;31(3):457-459
pubmed: 28079545
J Acquir Immune Defic Syndr. 2019 Aug 15;81(5):585-593
pubmed: 31045650
Clin Infect Dis. 2005 Dec 1;41(11):1648-53
pubmed: 16267739
AIDS. 2017 Mar 27;31(6):868-870
pubmed: 28272139
Nat Med. 2016 Aug 4;22(8):831-3
pubmed: 27490433
Lancet. 2014 Jun 28;383(9936):2222-31
pubmed: 24698485
Addiction. 2010 May;105(5):862-71
pubmed: 20331557
Drug Alcohol Depend. 2007 Jun 15;89(1):74-81
pubmed: 17291696
Curr Opin HIV AIDS. 2018 Mar;13(2):102-111
pubmed: 29278532
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
AIDS. 2017 Aug 24;31(13):1853-1858
pubmed: 28692533
AIDS. 2017 Jan 28;31(3):455-457
pubmed: 28079544
J Acquir Immune Defic Syndr. 2005 Apr 15;38(5):560-5
pubmed: 15793366
Eur Heart J. 2014 Jun 1;35(21):1365-72
pubmed: 24282187
HIV Med. 2017 Jan;18(1):56-63
pubmed: 27860104
N Engl J Med. 2013 Nov 7;369(19):1807-18
pubmed: 24195548
AIDS. 2016 Nov 28;30(18):2831-2834
pubmed: 27824625
Behav Res Ther. 1997 Jan;35(1):79-89
pubmed: 9009048
AIDS Behav. 2019 Mar;23(3):580-591
pubmed: 30269230

Auteurs

Lisa Van de Wijer (L)

Department of Internal Medicine, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands. l.vandewijer@radboudumc.nl.
Nijmegen Institute for Scientist Practitioners in Addiction, Nijmegen, The Netherlands. l.vandewijer@radboudumc.nl.

Wouter van der Heijden (W)

Department of Internal Medicine, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.

Mike van Verseveld (M)

Department of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands.

Mihai Netea (M)

Department of Internal Medicine, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.

Quirijn de Mast (Q)

Department of Internal Medicine, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.

Arnt Schellekens (A)

Nijmegen Institute for Scientist Practitioners in Addiction, Nijmegen, The Netherlands.
Department of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands.
Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, The Netherlands.

André van der Ven (A)

Department of Internal Medicine, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH